PhaseBio says biopolymer delivery tech could cut insulin injections
Diabetes sufferers could be injecting insulin just once a week if a new drug delivery technique is picked up by a big pharma company.
Archives for January 31, 2013
Flublok maker open to sharing egg and virus-free manufactuing tech
Protein Sciences says it will license the novel manufacturing technology behind recently approved influenza vaccine, Flublok, to other producers.
Cytovance ups biologics capacity as small pharma demand rises
Cytovance Biologics says an increase in demand from small pharma was the driving force in expanding its biologics capacity.